212 related articles for article (PubMed ID: 2758025)
1. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis.
Joshi UM; Rao P; Kodavanti S; Lockard VG; Mehendale HM
Biochim Biophys Acta; 1989 Aug; 1004(3):309-20. PubMed ID: 2758025
[TBL] [Abstract][Full Text] [Related]
2. Types of interaction of amphiphilic drugs with phospholipid vesicles.
Joshi UM; Kodavanti PR; Coudert B; Dwyer TM; Mehendale HM
J Pharmacol Exp Ther; 1988 Jul; 246(1):150-7. PubMed ID: 3392651
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence studies of the binding of amphiphilic amines with phospholipids.
Ma JY; Ma JK; Weber KC
J Lipid Res; 1985 Jun; 26(6):735-44. PubMed ID: 4031652
[TBL] [Abstract][Full Text] [Related]
4. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats.
Kodavanti UP; Lockard VG; Mehendale HM
J Biochem Toxicol; 1990; 5(4):245-51. PubMed ID: 1965728
[TBL] [Abstract][Full Text] [Related]
5. Association of chlorphentermine with phospholipids in rat alveolar lavage materials, alveolar macrophages and type II cells.
Ma JY; Ma JK; Weber KC; Bowman L; Reasor MJ; Miles PR
Biochim Biophys Acta; 1988 Feb; 958(2):163-71. PubMed ID: 3337832
[TBL] [Abstract][Full Text] [Related]
6. Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines.
Ploemen JP; Kelder J; Hafmans T; van de Sandt H; van Burgsteden JA; Saleminki PJ; van Esch E
Exp Toxicol Pathol; 2004 Mar; 55(5):347-55. PubMed ID: 15088636
[TBL] [Abstract][Full Text] [Related]
7. Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung.
Kodavanti UP; Mehendale HM
Am J Respir Cell Mol Biol; 1991 Apr; 4(4):369-78. PubMed ID: 2015101
[TBL] [Abstract][Full Text] [Related]
8. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
Lee P; Kirk RG; Reasor MJ
Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone-induced phospholipidosis in rat alveolar macrophages.
Reasor MJ; Ogle CL; Walker ER; Kacew S
Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811
[TBL] [Abstract][Full Text] [Related]
10. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
Reasor MJ
Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone--an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine.
Shaikh NA; Downar E; Butany J
Mol Cell Biochem; 1987 Aug; 76(2):163-72. PubMed ID: 2823097
[TBL] [Abstract][Full Text] [Related]
12. Emerging mechanisms of drug-induced phospholipidosis.
Breiden B; Sandhoff K
Biol Chem; 2019 Dec; 401(1):31-46. PubMed ID: 31408430
[TBL] [Abstract][Full Text] [Related]
13. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
[TBL] [Abstract][Full Text] [Related]
14. Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis.
Kuroda Y; Saito M
Toxicol In Vitro; 2010 Mar; 24(2):661-8. PubMed ID: 19786086
[TBL] [Abstract][Full Text] [Related]
15. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
Ohmiya Y; Angevine LS; Mehendale HM
Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
[No Abstract] [Full Text] [Related]
16. [A comparative morphological and chemical study of the ambroxol and chlorphentermine action on the lung phospholipid content (author's transl)].
Meerbach W; Gräbner R; Dietz W; Böttger W
Zentralbl Allg Pathol; 1982; 126(1-2):185-95. PubMed ID: 7090596
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
McCloud CM; Beard TL; Kacew S; Reasor MJ
Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone.
Hostetler KY; Giordano JR; Jellison EJ
Biochim Biophys Acta; 1988 Apr; 959(3):316-21. PubMed ID: 3355852
[TBL] [Abstract][Full Text] [Related]
19. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.
Heath MF; Costa-Jussà FR; Jacobs JM; Jacobson W
Br J Exp Pathol; 1985 Aug; 66(4):391-7. PubMed ID: 2992568
[TBL] [Abstract][Full Text] [Related]
20. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
Coulombe PA; Bendayan M
J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
